Background illustration for clinical trials search

Paid Clinical Trials Overland Park

Discover 722 paid clinical trials in Overland Park, Kansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

for
Atrial Fibrillation (AF), Persistant Atrial Fibrillation,
Location: Overland Park KS, Springfield IL, Jonesboro AR,
Sponsor: Arga Medtech SA

Sex: All

Age: 18 - 70+

Code: NCT06784466

Recruiting

Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial

for
Cardiovascular Disease
Location: Overland Park KS, Humble TX, Vaughan, Jacksonville FL,
Sponsor: Amgen

Sex: All

Age: 35 - 70+

Code: NCT07293260

Phase3, Recruiting

Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation

for
Atrial Fibrillation
Location: Overland Park KS, Evanston IL, Columbus OH, New York NY
Sponsor: Volta Medical

Sex: All

Age: 21+

Code: NCT06056271

Recruiting

Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry

for
Atrial Fibrillation, Ischemic Stroke, Acute
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 18+

Code: NCT06075628

Recruiting

Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy

for
Arrhythmias, Cardiac, Atrial Fibrillation
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT04473807

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

HS Students Mandatory Universal Student Instruction in CPR Appraised Learning- Is the Mandate Working?

for
Sudden Cardiac Arrest
Location: Overland Park KS
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 12 - 25

Code: NCT04493970

Recruiting

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

for
Aortic Stenosis, Coronary Artery Disease, Coronary Stenosis
Location: Overland Park KS, Kansas City KS, Columbia MO,
Sponsor: University of British Columbia

Sex: All

Age: 0+

Code: NCT04634240

Recruiting

Amyloidosis Incidence in High-Risk Cardiac Device Patients

for
Amyloid, Cardiac Amyloidosis, Amyloidosis Cardiac,
Location: Overland Park KS
Sponsor: Midwest Heart & Vascular Specialists

Sex: All

Age: 40+

Code: NCT06186167

Recruiting

Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab

for
Relapsing Multiple Sclerosis
Location: Overland Park KS, St Louis MO, Iowa City IA,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT05877963

Phase3, Recruiting

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Kansas City KS, Yukon OK, Chicago IL, Milwaukee WI,
Sponsor: Immunovant Sciences GmbH

Sex: All

Age: 18+

Code: NCT07032662

Phase2, Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Roeland Park KS, Lincoln NE, Omaha NE, Norman OK,
Sponsor: TG Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06433752

Recruiting

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

for
Graves Disease
Location: Lenexa KS, Kansas City MO, St Louis MO, Springfield IL,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18 - 70

Code: NCT07661056

Phase3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for
Uterine Fibroids, Endometriosis
Location: Lenexa KS, Wichita KS, St Louis MO, Grand Island NE,
Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase3, Recruiting

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

for
Multiple Myeloma
Location: Leawood KS, Kansas City KS, Merriam KS, Kansas City MO,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06152575

Phase3, Recruiting

MultiCenter IDE Study of the PEEK-OPTIMA™ Femoral Component vs a CoCr Alloy TKA Femoral Component of Similar Design

for
Knee Osteoarthritis
Location: Leawood KS, San Antonio TX
Sponsor: Maxx Orthopedics Inc

Sex: All

Age: 18+

Code: NCT06627673

Recruiting

Prospective, In-Vivo, Post-Market Safety and Efficacy Surveillance Registry of the MAXX Orthopedics, Freedom Total Knee® System

for
Knee Osteoarthristis, Total Knee Anthroplasty
Location: Leawood KS, San Antonio TX
Sponsor: Maxx Orthopedics Inc

Sex: All

Age: 18+

Code: NCT06627699

Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

for
Breast Cancer, Hereditary Breast and Ovarian Cancer
Location: Overland Park KS, Westwood KS, Kansas City MO,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 0+

Code: NCT02302742

Recruiting

Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System

for
Persistent Atrial Fibrillation
Location: Overland Park KS, Sarasota FL
Sponsor: Kansas City Heart Rhythm Research Foundation

Sex: All

Age: 18 - 70+

Code: NCT05826665

Recruiting

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

for
Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma
Location: Lenexa KS, Kansas City MO, Merriam KS, Omaha NE,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT06989437

Phase2, Phase3, Recruiting

Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)

for
Atrial Fibrillation (AF)
Location: Kansas City MO, Kansa City MO, Wichita KS,
Sponsor: Anthos Therapeutics, Inc.

Sex: All

Age: 65+

Code: NCT05712200

Phase3, Recruiting